$18.10
0.21[1.17%]
At close: Apr 26
$18.10
0[0.00%]
PreMarket: 8:23AM EDT
Oscar Health
(NYSE:OSCR)Oscar Health Stock (NYSE:OSCR), Analyst Ratings, Price Targets, Predictions
Oscar Health Inc has a consensus price target of $13.28, established from looking at the 32 latest analyst ratings. The last 3 analyst ratings were released from Raymond James, Wells Fargo, and Goldman Sachs on March 22, 2024, February 15, 2024, and February 9, 2024. With an average price target of $18.67 between Raymond James, Wells Fargo, and Goldman Sachs, there's an implied 3.13% upside for Oscar Health Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Raymond James
Wells Fargo
Goldman Sachs
B of A Securities
Morgan Stanley
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Oscar Health
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/22/2024 | OSCR | Buy Now | Oscar Health | $18.10 | 10.5% | Raymond James | John Ransom | → $20 | Initiates | → Outperform | Get Alert |
| 02/15/2024 | OSCR | Buy Now | Oscar Health | $18.10 | 10.5% | Wells Fargo | Stephen Baxter | $12 → $20 | Maintains | Overweight | Get Alert |
| 02/09/2024 | OSCR | Buy Now | Oscar Health | $18.10 | -11.6% | Goldman Sachs | Nathan Rich | $8 → $16 | Maintains | Neutral | Get Alert |
| 11/02/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -50.28% | B of A Securities | Adam Ron | $8 → $9 | Upgrade | Neutral → Buy | Get Alert |
| 08/30/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -58.56% | Morgan Stanley | Ricky Goldwasser | $5 → $7.5 | Maintains | Equal-Weight | Get Alert |
| 08/10/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -58.56% | Goldman Sachs | Nathan Rich | $5.5 → $7.5 | Maintains | Neutral | Get Alert |
| 08/09/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -53.04% | Credit Suisse | Jonathan Yong | $7 → $8.5 | Maintains | Outperform | Get Alert |
| 07/14/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -72.38% | Morgan Stanley | Ricky Goldwasser | $5 → $5 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/13/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -33.7% | Wells Fargo | Stephen Baxter | $8.5 → $12 | Maintains | Overweight | Get Alert |
| 06/06/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -51.66% | B of A Securities | Kevin Fischbeck | $5.4 → $8.75 | Upgrade | Underperform → Neutral | Get Alert |
| 05/17/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -53.04% | Wells Fargo | Stephen Baxter | $6.75 → $8.5 | Maintains | Overweight | Get Alert |
| 05/10/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -61.33% | Credit Suisse | Jonathan Yong | $6 → $7 | Maintains | Outperform | Get Alert |
| 03/29/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -78.45% | B of A Securities | Kevin Fischbeck | $3.25 → $3.9 | Maintains | Underperform | Get Alert |
| 02/14/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -66.85% | Cowen & Co. | Gary Taylor | $3 → $6 | Maintains | Market Perform | Get Alert |
| 02/14/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -72.38% | Goldman Sachs | Nathan Rich | $3.5 → $5 | Maintains | Neutral | Get Alert |
| 02/10/2023 | OSCR | Buy Now | Oscar Health | $18.10 | -66.85% | Credit Suisse | Jonathan Yong | $7 → $6 | Maintains | Outperform | Get Alert |
| 11/16/2022 | OSCR | Buy Now | Oscar Health | $18.10 | -77.9% | Wells Fargo | Stephen Baxter | → $4 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/14/2022 | OSCR | Buy Now | Oscar Health | $18.10 | -72.38% | Morgan Stanley | Ricky Goldwasser | $9 → $5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/01/2022 | OSCR | Buy Now | Oscar Health | $18.10 | -50.28% | Morgan Stanley | Ricky Goldwasser | $12 → $9 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Oscar Health (OSCR)?
The latest price target for Oscar Health (NYSE: OSCR) was reported by Raymond James on March 22, 2024. The analyst firm set a price target for $20.00 expecting OSCR to rise to within 12 months (a possible 10.50% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Oscar Health (OSCR)?
The latest analyst rating for Oscar Health (NYSE: OSCR) was provided by Raymond James, and Oscar Health initiated their outperform rating.
When was the last upgrade for Oscar Health (OSCR)?
The last upgrade for Oscar Health Inc happened on November 2, 2023 when B of A Securities raised their price target to $9. B of A Securities previously had a neutral for Oscar Health Inc.
When was the last downgrade for Oscar Health (OSCR)?
The last downgrade for Oscar Health Inc happened on November 14, 2022 when Morgan Stanley changed their price target from $9 to $5 for Oscar Health Inc.
When is the next analyst rating going to be posted or updated for Oscar Health (OSCR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Oscar Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Oscar Health was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.
Is the Analyst Rating Oscar Health (OSCR) correct?
While ratings are subjective and will change, the latest Oscar Health (OSCR) rating was a initiated with a price target of $0.00 to $20.00. The current price Oscar Health (OSCR) is trading at is $18.10, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.